健壮 发表于 2025-3-25 04:22:12

Submitted on: 08 April 2024.
Revised on: 26 June 2024.
Accepted on: 30 July 2024.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Indigence 发表于 2025-3-25 10:18:54

http://reply.papertrans.cn/2/185/18438/18438-22.png

模范 发表于 2025-3-25 15:35:46

Submitted on: 31 May 2008.
Revised on: 28 June 2008.
Accepted on: 30 July 2008.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

点燃 发表于 2025-3-25 17:32:10

http://reply.papertrans.cn/2/185/18438/18438-24.png

Schlemms-Canal 发表于 2025-3-25 21:22:09

http://reply.papertrans.cn/2/185/18438/18438-25.png

tic-douloureux 发表于 2025-3-26 01:37:12

http://reply.papertrans.cn/2/185/18438/18438-26.png

训诫 发表于 2025-3-26 04:32:11

Submitted on: 03 August 2019.
Revised on: 30 August 2019.
Accepted on: 01 October 2019.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

CESS 发表于 2025-3-26 12:03:31

http://reply.papertrans.cn/2/185/18438/18438-28.png

易于交谈 发表于 2025-3-26 15:36:14

Submitted on: 16 March 2012.
Revised on: 16 June 2012.
Accepted on: 05 July 2012.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

analogous 发表于 2025-3-26 19:15:32

http://reply.papertrans.cn/2/185/18438/18438-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS 2024/2025影响因子:1.963 (J OCUL PHARMACOL TH) (1080-7683). (PHARMACOL